Delivery Order SPE2DB22D2206-SPE2DB24FGR76
- Not listed
- This is a $7,052.88 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product REVATIO 20 MG TABLET 90S, with a period of performance through May 14, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
- This is a $23,283.83 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REVATIO 20 MG tablets to support federal healthcare programs. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a $16,837.90 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of REVATIO 20 MG TABLET 90S. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription drugs to support military treatment facilities and other government healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $11,138.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product, with a completion date of May 31, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of REVATIO 20 MG TABLET 90S. The contract has a ceiling value of $18,035.96 and an ultimate completion date of September 5, 2024. The order is a firm-fixed price contract, indicating a pre-determined price for the goods. AmerisourceBergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various...
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Revatio 20 mg tablets. The contract has a ceiling value of $2,855.68 and a performance period ending on July 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for $47,426.86. The contract is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of October 16, 2024 and is a firm fixed-price contract. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $19,836.35 firm fixed-price contract is for the delivery of REVATIO 20 MG tablets. The ultimate completion date is July 26, 2024. This order is not associated with a set-aside program. AmerisourceBergen has been awarded multiple IDCs by various government agencies, including the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,866.34, is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,021.74 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 90 tablets of Revatio 20 mg, a medication used to treat pulmonary arterial hypertension. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGR76Delivery Order
This is a $17,822.83 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product, with a period of performance through April 16, 2024. The award does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical, valued up to $999,999,999.00, as well as the Department of Justice Federal Bureau of Investigation, valued up to $750,000, for the provision of a comprehensive range of pharmaceutical and medical commodities to support government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 4/15/24 |